Raily Aesthetic Medicine International Holdings Ltd.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: KYG7356A1058

HKD

0.15

0.04 (33.93%)

Feb 16

HKG

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Fameglow Holdings Ltd.

Miricor Enterprises Holdings Ltd.

Kato (Hong Kong) Holdings Ltd.

Kindstar Globalgene Technology, Inc.

Aidigong Maternal & Child Health Ltd.

Clarity Medical Group Holding Ltd.

Meihao Medical Group Co., Ltd.

New Century Healthcare Holding Co., Ltd.

Human Health Holdings Ltd.

UMP Healthcare Holdings Ltd.

Raily Aesthetic Medicine International Holdings Ltd.

Why is Raily Aesthetic Medicine International Holdings Ltd. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Raily Aesthetic Medicine International Holdings Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Raily Aesthetic Medicine International Holdings Ltd.

-100.0%

0.06

68.21%

Hang Seng Hong Kong

18.06%

0.71

25.51%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.10%

EBIT Growth (5y)

-200.36%

EBIT to Interest (avg)

-3.81

Debt to EBITDA (avg)

0.11

Net Debt to Equity (avg)

0.04

Sales to Capital Employed (avg)

1.07

Tax Ratio

3.06%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.60

EV to EBIT

-3.50

EV to EBITDA

6.82

EV to Capital Employed

0.61

EV to Sales

0.33

PEG Ratio

Dividend Yield

ROCE (Latest)

-17.50%

ROE (Latest)

-21.05%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Raily Aesthetic Medicine International Holdings Ltd.

Net Profit

Higher at HKD -21.58 MM

than preceding 12 month period ended Dec 2024

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

Here's what is not working for Raily Aesthetic Medicine International Holdings Ltd.

Debt-Equity Ratio

Highest at 26.41 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

EPS

Lowest at HKD -0.11

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (HKD)

Cash and Eqv

Lowest at HKD 30.72 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio

Lowest at 13.89%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 12.7% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales